Home No Rehearing Of Biosimilar Patent Dance Decision
 

Keywords :   


No Rehearing Of Biosimilar Patent Dance Decision

2015-10-21 00:14:28| Biotech - Topix.net

The Federal Circuit denied the petitions for rehearing en banc filed in Amgen Inc. v. Sandoz Inc. , which was the court's first decision interpreting the Biologics Price Competition and Innovation Act .

Tags: decision dance patent rehearing

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
More »